Background: There is a well-known association between type 2 diabetes (T2DM) and depression, including inferior outcomes in weight loss treatments. However, obesity guidelines do not address psychiatric interventions during such programs.

Objective: We assessed the impact of T2DM in outcomes (weight loss, psychiatric diagnoses and quality of life) of a six-month public obesity program that incorporated a psychiatric intervention for patients with severe obesity.

Methods: Retrospective analysis of the registry of the behavioral obesity program at Instituto Nacional de Ciencias Médicas y Nutrición in Mexico City after implementation of a psychiatric intervention that includes diagnosis by a single psychiatrist with the DSMV criteria, psychoeducation, psychopharmacological prescription and/or psychotherapy accordingly. We determined weight loss, frequency of psychiatric diagnoses (depression, anxiety, binge eating disorder [BED]), and quality of life according with T2DM diagnosis.

Results: We included 329 subjects (66% women aged 43.7±12.2 years, initial BMI of 44.2±9.6 kg/m2). The frequency of psychiatric diagnoses in patients with and without T2DM was: Depression 43% and 32% (p=0.05), anxiety 25% and 24% (p=0.42), and BED 32% and 32% (p=0.50). Baseline quality of life (QoL) was lower in patients with T2DM than in those without it (p<0.001), and both were prescribed a pharmacological treatment similarly. Subjects with T2DM were prescribed an obesity drug more often (p=0.004) but lost similar weight (p=0.07). Patients with T2DM had higher depression remission, to similar frequency at the end (p=0.42), and QoL improved significantly (p=0.02), but remained lower than in subjects without T2DM (p<0.001).

Conclusion: In subjects with severe obesity and T2DM, pharmacological obesity treatment and a psychiatric intervention and were beneficial for weight loss and depression control. Improvement in QoL might require additional T2DM interventions.

Disclosure

M. Rodriguez Flores: None. S. Stephano Z.: None. M. Rabasa: None. J. Montoya: None. C. Velez: None. E. Garcia: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.